| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d77e120d1588e76c73afc1a3197a126 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea27534234267048fca08ef7535073a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e569478bf982fa937f66b6f13e444d24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccee8c21bd54e60eca5954b8de9e6387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbdc81e9ef6d475a1737f74515d1346c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f305be09fe6b7698ea3d48f8c157fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cdacecfa6bc3684759e6603d1d3cda
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3c967d778a03d09bffcf2bfea18cd6e |
| publicationDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090058566-A |
| titleOfInvention |
Therapeutic compositions for improving the effect of antibody treatment against epidermal growth factor receptor antibodies |
| abstract |
The present invention describes certain therapeutic compositions that increase the efficacy of therapeutic treatment with monoclonal antibodies against epidermal growth factor receptor (EGFR) in combination with Type I IFNs. |
| priorityDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |